Hyperimmunized patients awaiting cadaveric kidney graft: Is there a quick desensitization possible?

被引:1
|
作者
Faenza, A. [1 ]
Fuga, G. [1 ]
Bertelli, R. [1 ]
Scolari, M. P. [2 ]
Buscaroli, A. [2 ]
Stefoni, S. [2 ]
机构
[1] S Orsola Univ Hosp, Dept Kidney Transplant Surg & Nephrol, Bologna, Italy
[2] S Orsola Univ Hosp, Dept Dialysis & Transplantat, Bologna, Italy
关键词
D O I
10.1016/j.transproceed.2008.05.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
On all kidney waiting lists the 10% to 20% of patients who have antibodies against more than 80% of a panel of HLA antigens (panel reactive antibody [PRA] > 80%) are difficult to transplant. The best solution for these patients is to find a compatible donor, ideally a full match, who yields a negative crossmatch test (CMX). If this is not possible, desensitization treatment (high-dose) intravenous immunoglobulin (IVIG) or plasmapheresis (PP) + low-dose IVIG is possible with good results in living donor kidney transplantation mainly if the antibody titer is low. It may also be offered to patients awaiting cadaveric donors too after a long waiting time; however, when applied for several months, it has the obvious disadvantage of giving the patient the risk for long-lasting immunologic weakness without the certitude of finding a kidney. In one of our recent cases of combined liver plus kidney transplantation, a positive CMX became negative 8 hours after the liver operation; the kidney was transplanted with a good result which lasted over 3 years. This observation Suggested the possibility of a quick desensitization protocol in selected patients with a large (but not strong) immunization who probably are the majority. Patients sensitized to IVIG and with low titer PRA could be given a single PP + low-dose IVIG (what can be done within the time limit of cadaveric donor kidney transplantation) with good probability of turning an initial positive CMX to negative with the possibility of performing the operation and the advantage of giving the immunosuppression only when the kidney is present.
引用
收藏
页码:1833 / 1838
页数:6
相关论文
共 50 条
  • [1] EFFICACY OF DESENSITIZATION TREATMENT IN HYPERIMMUNIZED PATIENTS AWAITING A CADAVERIC KIDNEY TRANSPLANTATION
    Gonzalez Garcia, Maria Elena
    Lopez Oliva, Maria Ovidia
    Mancebo, Esther
    Jimenez, Carlos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I948 - I948
  • [2] Efficacy and Safety of a Desensitization Treatment With Rituximab and Immunoglobulin in Hyperimmunized Patients Awaiting a Cadaveric Kidney Transplantation
    Garcia, Elena Gonzalez
    Oliva, Maria Lopez
    Mancebo, Esther
    Santana, Maria Jose
    Machado, Lina Maria Leon
    Fernandez, Cristina Fuentes
    Jimenez, Carlos
    TRANSPLANTATION PROCEEDINGS, 2025, 57 (01) : 3 - 6
  • [3] EFFECT OF PROTEIN-A IMMUNOADSORPTION ON PANEL LYMPHOCYTE-REACTIVITY IN HYPERIMMUNIZED PATIENTS AWAITING A KIDNEY GRAFT
    ESNAULT, V
    BIGNON, JD
    TESTA, A
    PREUDHOMME, JL
    VERGRACHT, A
    SOULILLOU, JP
    TRANSPLANTATION, 1990, 50 (03) : 449 - 453
  • [4] Effects of Desensitization Therapy on Acute Rejection and Graft Function in Patients Who Are Hyperimmunized after Receiving a Living-Donor Kidney Transplant
    Castro, Caren Dolores
    Andrade-Sierra, Jorge
    Reynoso de la Torre, Hugo Leonardo
    Hugo, Leonardo
    Rojas-Campos, Enrique
    Evangelista-Carrillo, Luis Alberto
    Carvallo Venegas, Mauricio
    Banda Lopez, Adriana
    Cerrillos, Jose Ignacio
    Medina Perez, Miguel
    Munoz, Diana Laura
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [5] Non Active Desensitization Protocol: Improving Access to Kidney Transplant for Hyperimmunized Patients.
    Le Bot, S.
    Delbos, F.
    Garandeau, C.
    Castagnet, S. Malard
    Cesbron, A.
    Hourmant, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 526 - 526
  • [6] Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation
    Gill, JS
    Ma, I
    Landsberg, D
    Johnson, N
    Levin, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03): : 808 - 816
  • [7] Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant
    Vincenti, Flavio
    Bestard, Oriol
    Brar, Amarpali
    Cruzado, Josep M.
    Seron, Daniel
    Gaber, A. Osama
    Ali, Nicole
    Tambur, Anat R.
    Lee, Helen
    Abbadessa, Giovanni
    Paul, Jo-Anne
    Dudek, Markus
    Siegel, Ruby J.
    Torija, Alba
    Semiond, Dorothee
    Lepine, Lucie
    Ternes, Nils
    Montgomery, Robert A.
    Stegall, Mark
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (03): : 347 - 360
  • [8] Graft and Patient Survival in Hyperimmunized Liver-Kidney and Kidney Transplant Recipients
    Rodriguez-Espinosa, D.
    Broseta, J.
    Cuadrado-Payan, E.
    Cucchiari, D.
    Ventura Aguiar, P.
    Cofan, F.
    Torregrosa, V.
    Oppenheimer, F.
    Diekmann, F.
    Colmenero, J.
    Esforzado, N.
    Revuelta, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S698 - S698
  • [9] Use of a Desensitization Protocol in Highly Sensitized yet Immunocompromised Patients Awaiting Kidney Transplantation
    Guerra, Juan Francisco
    Cummings, Lee S.
    Hawksworth, Jason S.
    Desai, Chirag S.
    Flanagan, Eleisha
    Girlanda, Rafaelle
    Johnson, Lynt B.
    Melancon, Joseph K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 72 - 72
  • [10] The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: Short waiting time and excellent graft outcome
    Claas, FHJ
    Witvliet, MD
    Duquesnoy, RJ
    Persijn, GG
    Doxiadis, IIN
    TRANSPLANTATION, 2004, 78 (02) : 190 - 193